✦ LIBER ✦

Oxaliplatin in Combination With Infusional 5-Fluorouracil as First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Phase II Study of the Spanish Cooperative Group for the Treatment of Digestive Tumors

✍ Scribed by Benavides, Manuel; Pericay, Carles; Valladares-Ayerbes, Manuel; Gil-Calle, Silvia; Massutí, Bartomeu; Aparicio, Jorge; Dueñas, Rosario; González-Flores, Encarna; Carrato, Alfredo; Marcuello, Eugenio; Gómez, Auxiliadora; Cabrera, Enrique; Queralt, Bernardo; Gómez, Ma José; Guasch, Inmaculada; Etxeberría, Arantxa; Alfaro, Jordi; Campos, Juan Manuel; Reina, Juan José; Aranda, Enrique

Book ID: 122776711
Publisher: CIG Media Group, LP.
Year: 2012
Tongue: English
Weight: 311 KB
Volume: 11
Category: Article
ISSN: 1533-0028
DOI: 10.1016/j.clcc.2012.01.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6055 A randomized phase II study of Xelo

6055 A randomized phase II study of Xeloda with or without oxaliplatin as a first-line treatment in the elderly patients with metastatic colorectal cancer: Korean Cancer Study Group

✍ Hong, Y.S.; Kim, S.Y.; Jung, K.H.; Lee, J.L.; Park, Y.S.; Ahn, J.B.; Kim, J.H.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Biweekly oxaliplatin combined with oral

Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study

✍ P. Comella; B. Massidda; S. Palmeri; A. Farris; L. De Lucia; D. Natale; L. Maior 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 190 KB

Capecitabine in combination with irinote

Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group

✍ Garcia-Alfonso, P; Muñoz-Martin, A; Mendez-Ureña, M; Quiben-Pereira, R; Gonzalez 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

A multicenter phase II clinical study of

A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as first-line treatment for advanced colorectal cancer: A Japanese experience

✍ Hideo Baba; Naoko Hayashi; Yasunori Emi; Yoshihiro Kakeji; Akinori Egashira; Eij 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 143 KB

Phase I/II study of oxaliplatin with ora

Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer

✍ Yamada, Y; Tahara, M; Miya, T; Satoh, T; Shirao, K; Shimada, Y; Ohtsu, A; Sasaki 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB

Use of the folinic acid/5-fluorouracil/i

Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study

✍ Eric François; Jean-François Berdah; Emmanuel Chamorey; Gérard Lesbats; Eric Tei 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 286 KB